Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Muscle Relaxant Drugs Market, by Drug Type
1.4.2 North America Muscle Relaxant Drugs Market, by Route of Administration
1.4.3 North America Muscle Relaxant Drugs Market, by Distribution Channel
1.4.4 North America Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Muscle Relaxant Drugs Market by Drug Type
3.1 North America Skeletal Market by Country
3.2 North America Neuromuscular Blocking Agents Market by Country
3.3 North America Facial Muscle Relaxant Drugs Market by Country
Chapter 4. North America Muscle Relaxant Drugs Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Injectable Market by Country
Chapter 5. North America Muscle Relaxant Drugs Market by Distribution Channel
5.1 North America Hospital Pharmacy Market by Country
5.2 North America Retail Pharmacy Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Muscle Relaxant Drugs Market by Country
6.1 US Muscle Relaxant Drugs Market
6.1.1 US Muscle Relaxant Drugs Market by Drug Type
6.1.2 US Muscle Relaxant Drugs Market by Route of Administration
6.1.3 US Muscle Relaxant Drugs Market by Distribution Channel
6.2 Canada Muscle Relaxant Drugs Market
6.2.1 Canada Muscle Relaxant Drugs Market by Drug Type
6.2.2 Canada Muscle Relaxant Drugs Market by Route of Administration
6.2.3 Canada Muscle Relaxant Drugs Market by Distribution Channel
6.3 Mexico Muscle Relaxant Drugs Market
6.3.1 Mexico Muscle Relaxant Drugs Market by Drug Type
6.3.2 Mexico Muscle Relaxant Drugs Market by Route of Administration
6.3.3 Mexico Muscle Relaxant Drugs Market by Distribution Channel
6.4 Rest of North America Muscle Relaxant Drugs Market
6.4.1 Rest of North America Muscle Relaxant Drugs Market by Drug Type
6.4.2 Rest of North America Muscle Relaxant Drugs Market by Route of Administration
6.4.3 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Amneal Pharmaceuticals, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Company Overview
7.4 Mallinckrodt PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Endo International PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
7.8.1 Company Overview
7.9 SteriMax Inc.
7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
7.10.1 Company Overview
Unique Offerings 